510(k) device
Helios Dermal Scaffold
Helios Biomedical, Inc. · Wound Dressing With Animal-Derived Material(S) (KGN, Unclassified) · First FDA decision Aug 15, 2025, newest Aug 15, 2025BurnsChronic wounds and ulcers
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
12
Naming "Dermal Scaffold"
MAUDE reports
0
Brand "Dermal Scaffold", since 2015
PubMed studies
111
Mentioning "Dermal Scaffold"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Helios Dermal Scaffold
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Helios Dermal Scaffold510(k)
K250397 · Decided Aug 15, 2025 · 184 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Dermal Scaffold", any status and sponsor, newest update first.
- Miro3D Wound Matrix for Treatment of Diabetic Foot UlcersPivotal-lookingRecruiting
Reprise Biomedical, Inc.Not on our public-company list
NCT07632001 · 180 participants (planned) · Start Jun 15, 2026 · Primary completion Mar 2027
Device: Miro3D Wound Matrix · For: Diabetic Foot Ulcers (DFUs); Diabetic Foot; Chronic Wounds
Sites: Phoenix, Arizona; Coconut Creek, Florida; Coral Gables, Florida · 14 sites in all
- Comparative Efficacy of ADM Hydrogel vs. Alginate Dressings in Chronic Trauma WoundsPivotal-lookingNot yet recruiting
Isfahan University of Medical SciencesAcademic, hospital or other
NCT06978569 · 130 participants (planned) · Start Jul 2025 · Primary completion Jul 2026
Device: Injectable Acellular dermal matrix hydrogel; Alginate dressing · For: Trauma Wounds
Sites: Isfahan, Iran
Integra LifeSciences CorporationPublic (IART)
NCT01612806 · 31 participants · Start Jun 2011 · Primary completion Feb 2017
Device: PriMatrix; PriMatrix Ag · For: Venous Stasis Ulcer
Sites: San Juan, Puerto Rico; Ponce, Puerto Rico; Vega Baja, Puerto Rico · 5 sites in all
9 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Dermal Scaffold", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code KGN
154 reports: 32 malfunction, 117 injury, 1 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Dermal Scaffold"[tiab]. The summary above synthesizes these.
- Quantitative nanohistology of aging dermal collagen.
Huang S, Strange A, Maeva A, et al. · Front Aging · 2023
- 3D Printed Bioactive PLGA Dermal Scaffold for Burn Wound Treatment.
Teo YC, Abbas A, Park EJ, et al. · ACS Mater Au · 2023
- Artificial Dermal Scaffold Loaded with Platelet-Rich Plasma Promotes Wound Healing in Pigs by Favoring Angiogenesis.
Li ZH, Wu GF, Song HQ, et al. · Med Sci Monit · 2022
- Wound healing properties of a fibrin-based dermal replacement scaffold.
Brown SJ, Surti F, Sibbons P, et al. · Biomed Phys Eng Express · 2021Research Support, Non-U.S. Gov't
- Comparison of Decellularized Human Dermal Scaffolds versus Bovine Collagen/Elastin Matrices for Engineering of Soft-Tissue Flaps.
Falkner F, Mayer SA, Heuer M, et al. · Plast Reconstr Surg · 2024Research Support, Non-U.S. Gov't
- Decellularization and preservation of human skin: A platform for tissue engineering and reconstructive surgery.
Brouki Milan P, Pazouki A, Joghataei MT, et al. · Methods · 2020Research Support, Non-U.S. Gov't
- Antimicrobial effectiveness of wound matrices containing native extracellular matrix with polyhexamethylene biguanide.
Davis SC, Gil J, Solis M, et al. · Int Wound J · 2022
- SKIN SUBSTITUTES IN RECONSTRUCTION SURGERY: THE PRESENT AND FUTURE PERSPECTIVES.
Knoz M, Holoubek J, Lipový B, et al. · Acta Chir Plast · 2020
- The response of tenocytes to commercial scaffolds used for rotator cuff repair.
Smith RD, Carr A, Dakin SG, et al. · Eur Cell Mater · 2016Research Support, Non-U.S. Gov't
- Use of fetal bovine dermal repair scaffold in diabetic foot ulcers with recidivism: an open-label prospective clinical study.
Lullove E · J Wound Care · 2023Clinical Trial
- Optical coherence tomography for in vivo longitudinal monitoring of artificial dermal scaffold.
Chen Z, Cheng Q, Wang L, et al. · Lasers Surg Med · 2023Research Support, Non-U.S. Gov't
- Application of a meshed artificial dermal scaffold and negative-pressure wound therapy in the treatment of full-thickness skin defects: a prospective in vivo study.
Wei P, Wu L, Xie H, et al. · Biomater Sci · 2024
Other devices of this type
Also filed under product code KGN.
- Cytal® Wound MatrixAcell, Inc. · 510(k) 2024
- PriMatrix Dermal Repair ScaffoldTei Biosciences, Inc. · 510(k) 2016
- Marigen Wound ExtraKerecis Limited · 510(k) 2025
- MatriDermMedskin Solutions Dr. Suwelack AG · 510(k) 2026
- CollOvine Wound PowderOvigenex, LLC · 510(k) 2026
- SurgiAid Collagen Wound Dressing (HA)Maxigen Biotech, Inc. · 510(k) 2025
- Collagen Wound DressingWinner Medical Co., Ltd. · 510(k) 2025
- Corplex P/ Theracor P/ Allacor PStimlabs, LLC · 510(k) 2024
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.